Inhibitor studies in mouse models showed that HDAC11 plays an important role in oncogene-induced hematopoiesis in myeloproliferative neoplasms (MPNs) (Yue et al., 2020). This evidence concerns the gene HDAC11 and myeloproliferative disorder.